Syndax Pharmaceuticals, Inc. (SNDX) Capital expenditures 2016–2025
Syndax Pharmaceuticals, Inc. (SNDX) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$187,000FY2025 · since FY2016: $261,000 → $187,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $187,000 | — |
| FY2024 | $0 | — |
| FY2023 | $0 | — |
| FY2022 | $0 | -100.0% |
| FY2021 | $129,000 | — |
| FY2020 | $0 | — |
| FY2018 | $187,000 | +122.6% |
| FY2017 | $84,000 | -67.8% |
| FY2016 | $261,000 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice